2016
DOI: 10.3233/jad-150158
|View full text |Cite
|
Sign up to set email alerts
|

Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer’s Dementia

Abstract: Abstract. Neurofibrillary pathology in Alzheimer's dementia (AD) is associated with cognitive impairments and cortical thinning, and begins in medial perirhinal cortex (mPRC) before entering entorhinal cortex (ERC). Thus, mPRC dysfunction (e.g., semantic object memory impairments) may predate or accompany ERC (i.e., episodic memory) dysfunction in the preclinical course of typical AD. We developed formulae estimating mPRC and ERC integrity (i.e., cortical thickness) using common neuropsychological tests in 31 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
26
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 29 publications
(28 citation statements)
references
References 43 publications
2
26
0
Order By: Relevance
“…Specifically, effect sizes for age differences in incorrect trials required to learn similar object discriminations in Experiment 1 (Cohen's d 5 1.34, 95% confidence interval (CI) 5 -22 to 20) and performance on Lure 2 (d 5 2.30, CI 5 -.56 to 5.16) and Lure 3 trials (d 5 1.98, CI 5 -.79 to 4.75) in Experiment 2 are greater than that observed for the age difference in performance on high-similarity spatial discriminations in our previously published study (d 5 .99, CI 5 .95-1.03) (Johnson et al, 2016). Critically, these findings are consistent with knowledge that lateral entorhinal and perirhinal cortices, which are more likely to contribute to visual and object discriminations, show earlier evidence of neuropathology with advanced age and progression to Alzheimer's disease (Braak & Braak, 1991;Braak, Braak, & Bohl, 1993;Hirni et al, 2016;Krumm et al, 2016;Khan et al, 2014).…”
Section: Domain-general Discrimination Deficits With Aging As They supporting
confidence: 86%
“…Specifically, effect sizes for age differences in incorrect trials required to learn similar object discriminations in Experiment 1 (Cohen's d 5 1.34, 95% confidence interval (CI) 5 -22 to 20) and performance on Lure 2 (d 5 2.30, CI 5 -.56 to 5.16) and Lure 3 trials (d 5 1.98, CI 5 -.79 to 4.75) in Experiment 2 are greater than that observed for the age difference in performance on high-similarity spatial discriminations in our previously published study (d 5 .99, CI 5 .95-1.03) (Johnson et al, 2016). Critically, these findings are consistent with knowledge that lateral entorhinal and perirhinal cortices, which are more likely to contribute to visual and object discriminations, show earlier evidence of neuropathology with advanced age and progression to Alzheimer's disease (Braak & Braak, 1991;Braak, Braak, & Bohl, 1993;Hirni et al, 2016;Krumm et al, 2016;Khan et al, 2014).…”
Section: Domain-general Discrimination Deficits With Aging As They supporting
confidence: 86%
“…Given prior findings of PRC dysfunction in animal models of aging (Burke et al, 2011(Burke et al, , 2014Ryan et al, 2012) and AD-related pathology in the region (Braak, Braak, and Bohl, 1993;Braak and Braak, 1995;Hirni et al, 2016;Jack et al, 1997), it is interesting and perhaps surprising that we found no evidence for age-related PRC dysfunction. One possibility is that mnemonic discrimination more uniquely drives age-related differences in alEC than PRC in the context of our task.…”
Section: Discussionmentioning
confidence: 44%
“…Moreover, it will be important to distinguish simple agerelated changes from those that indicate a disease state. The entorhinal cortex (EC) is among the first and most profoundly affected regions in age-related pathologies, such as Alzheimer's disease (AD) (Braak, Braak, and Bohl, 1993;Braak and Braak, 1995;Hirni et al, 2016;Jack et al, 1997). In particular, the EC, undergoes structural and functional alterations relating to AD (Burke et al, 2011(Burke et al, , 2014Ryan et al, 2012;Stranahan and Mattson, 2010), even in older preclinical humans (Khan et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…These changes can occur early in disease progression, especially in Parkinson’s disease (PD) and Alzheimer’s disease (AD) [1, 2], in some cases even before diagnosis [3, 4]. Animal models of these diseases are important for translational medicine, including development and testing of new drug and behavioral treatments [5, 6, 7, 8].…”
Section: Introductionmentioning
confidence: 99%